Both Moderna ( MRNA 4.37% ) and BioNTech ( BNTX 3.63% ) benefited Tuesday from a timely reminder that the coronavirus pandemic isn’t yet over. The Food and Drug Administration (FDA) amending its authorizations for the pair’s COVID vaccines. Moderna enjoyed a nearly 4.4% boost to its share price, while BiNTech closed the day 3.6% higher. The FDA gave the nod for a second booster shot for people aged 50 and older of both Moderna’s. Spikevax and Comirnaty are two of the best weapons we have to fight off the coronaviirus. So this latest regulatory green light is not only a positive development for Moderna, . . .
Read more at www.fool.com